Context: Most patients with neuro-urological disorders require life-long medical care. The European Association of Urology (EAU) regularly updates guidelines for the diagnosis and treatment of these patients.

Objective: To provide a summary of the 2015 updated EAU Guidelines on Neuro-Urology.

Evidence Acquisition: Structured literature searches in several databases were carried out to update the 2014 guidelines. Levels of evidence and grades of recommendation were assigned where possible.

Evidence Synthesis: Neurological disorders often cause urinary tract, sexual, and bowel dysfunction. Most neuro-urological patients need life-long care for optimal life expectancy and quality of life. Timely diagnosis and treatment are essential to prevent upper and lower urinary tract deterioration. Clinical assessment should be comprehensive and usually includes a urodynamic investigation. The neuro-urological management must be tailored to the needs of the individual patient and may require a multidisciplinary approach. Sexuality and fertility issues should not be ignored. Numerous conservative and noninvasive possibilities of management are available and should be considered before a surgical approach is chosen. Neuro-urological patients require life-long follow-up and particular attention has to be paid to this aspect of management.

Conclusions: The current EAU Guidelines on Neuro-Urology provide an up-to-date overview of the available evidence for adequate diagnosis, treatment, and follow-up of neuro-urological patients.

Patient Summary: Patients with a neurological disorder often suffer from urinary tract, sexual, and bowel dysfunction and life-long care is usually necessary. The update of the EAU Guidelines on Neuro-Urology, summarized in this paper, enables caregivers to provide optimal support to neuro-urological patients. Conservative, noninvasive, or minimally invasive approaches are often possible.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.07.071DOI Listing

Publication Analysis

Top Keywords

eau guidelines
16
guidelines neuro-urology
12
diagnosis treatment
12
urinary tract
12
neuro-urological patients
12
european association
8
association urology
8
urology eau
8
require life-long
8
tract sexual
8

Similar Publications

Background: Multidisciplinary teams (MDTs) are essential for cancer care but are resource-intensive. Decision-making processes within MDTs, while critical, contribute to increased healthcare costs due to the need for specialist time and coordination. The recent emergence of large language models (LLMs) offers the potential to improve the efficiency and accuracy of clinical decision-making processes, potentially reducing costs associated with traditional MDT models.

View Article and Find Full Text PDF

Presentation, Treatment and Outcomes of Brachial Artery Aneurysms.

J Vasc Surg

January 2025

Department of Cardiovascular Surgery, Mayo Clinic Health System, Eau Claire, WI. Electronic address:

Objective: Brachial artery aneurysms are rare entities that have typically been associated with trauma, infection, arterio-venous fistula creation or connective tissue disorders. These aneurysms are often asymptomatic, but they can also cause local tenderness or thrombo-embolic events. Due to the very low incidence of true brachial artery aneurysms, there are no standardized guidelines on their optimal management.

View Article and Find Full Text PDF

Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation.

Eur J Surg Oncol

December 2024

Oncologic Minimally Invasive Urology and Andrology Unit, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.

Background And Objectives: Enhanced Recovery After Surgery (ERAS) guidelines for Radical Cystectomy (RC) were published over ten years ago. Aim of this systematic review is to update ERAS recommendations for patients undergoing RC and to give an expert opinion on the relevance of each single ERAS item.

Methods: A systematic review was performed to identify the impact of each single ERAS item on RC outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine if diffuse, bilateral PI-RADS 3 changes on MRI of the prostate indicate clinically significant prostate cancer (csPCa).
  • Data from 108 men with these MRI findings who underwent biopsies were analyzed, and it was found that 30.5% were diagnosed with csPCa.
  • A significant correlation was identified between prostate-specific antigen density (PSAd) and the presence of cancer, suggesting that careful evaluation is needed before dismissing the need for biopsy in these cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!